Clinical psychologist Cheri Levinson of the University of Louisville says she is seeing more eating disorder patients with more severe symptoms than at any point in her nearly 20-year career, including growing numbers misusing GLP-1 weight-loss drugs. Separately, a study in JAMA Psychiatry led by Ruhai Bai of Children's Hospital of Nanjing Medical University estimated the incidence of anorexia and bulimia across 204 countries and territories from 1990 to 2023, finding rising global health burden from these conditions.
technologyreview.com
· 2026-10-30
A study by startup studio Deep Science Ventures found that UK fruits and vegetables have lost between 20% and 50% of nutrients like potassium, magnesium and copper since the 1960s, meaning people now need to eat roughly twice as much produce to get the same mineral intake. Researchers attribute the decline to degraded soil quality and crop breeding focused on fast growth rather than nutritional content.
science.slashdot.org
· 2026-10-11
MIT Technology Review's newsletter highlights two stories: one on the difficulty AI systems face in reliably refusing dangerous requests, such as help with pathogens or weapons, and another summarizing emerging research into side effects of GLP-1 weight-loss drugs, including possible links to hair loss, nail disorders and eye nerve damage. The AI piece notes that restricting dangerous capabilities also risks limiting useful applications like cancer research, while giving governments power to set their own boundaries on speech.
technologyreview.com
· 2026-10-09
Novo Nordisk, the Danish pharmaceutical company known for Ozempic and Wegovy, is rebranding itself as simply 'Novo' starting this week. The move shifts the company's public identity toward a shorter, more casual name as it markets directly to consumers rather than solely to healthcare providers.
fastcompany.com
· 2026-09-16
The Guardian gathered reader accounts describing how GLP-1 drugs like Wegovy, Ozempic and Mounjaro have reshaped family dynamics, with many users hiding their use out of shame. Several described feeling they had 'cheated' at weight loss, straining relationships with partners, children and friends who didn't know about the medication.
futurism.com
· 2026-09-12
A growing number of children and teenagers with obesity or type 2 diabetes are being prescribed GLP-1 medications, drugs originally developed for adults. Physicians and researchers say long-term safety and developmental effects of these treatments in younger patients remain largely unstudied.
gizmodo.com
· 2026-09-12
Chinese pharmaceutical companies, once known mainly for producing cheap generic medicines, are now developing original obesity and weight-loss drugs aimed at competing with Western blockbusters like Ozempic and Wegovy. Several firms are advancing candidates through clinical trials and striking licensing deals with major international drugmakers.
wsj.com
· 2026-09-11
GoKawiil